Responsibilities:
- Lead development and execution of integrated worldwide and US medical strategies for mavacamten across indications and lifecycle stages.
- Translate global medical strategy into region-specific medical plans; drive cross-functional alignment (development, regulatory, access, commercialization).
- Serve as global/US medical subject matter expert in hypertrophic cardiomyopathy (HCM).
- Lead content generation, disease education, data interpretation; act as trusted medical advisor.
- Contribute to evidence planning (RWE, Phase 4 studies, registries, investigator-sponsored research).
- Own global/US publication and content strategy; review abstracts/manuscripts/congress materials; support medical review processes.
- Provide medical leadership for congress strategy/execution.
- Establish/maintain Thought Leader Engagement Strategy and manage related activities (e.g., advisory boards).
- Support medical training and ensure consistent scientific messaging; ensure compliance with medical governance/policies.
Qualifications & Experience:
- Advanced scientific degree (MD, PhD, PharmD, PA/NP).
- 5β10+ years in Medical Affairs in pharma/biotech with increasing responsibility.
- Strong CV expertise required; HCM/rare disease experience preferred.
- Experience supporting global and US medical strategy; cross-functional success in matrixed organizations.
- Experience with multi-functional teams and managing external agencies; plan/implement medical congresses and advisory boards.
Skills/Competencies:
- Strong scientific/clinical acumen; translate data into actionable strategy.
- Excellent communication, relationship-building, and leadership in ambiguity; high integrity and judgment.
Compensation/Benefits (as stated):
- Princeton, NJ: $207,490β$251,433; additional incentive opportunities may be available; health, wellbeing programs, 401(k), disability/life insurance; paid time off (varies by location).
Application Instructions:
- Encouraged to apply even if experience doesnβt perfectly match.